Increased liver enzymes and hormonal therapies in girls and adolescents with Turner syndrome

被引：0
作者：
M. Wasniewska
R. Bergamaschi
P. Matarazzo
B. Predieri
S. Bertelloni
A. Petri
M. Sposito
M. F. Messina
F. De Luca
机构：
[1] University of Messina,Department of Pediatrics
[2] University of Bologna,Department of Pediatrics
[3] Regina Margherita Hospital of Turin,Division of Pediatric Endocrinology
[4] University of Modena,Department of Pediatrics
[5] University of Pisa,Department of Pediatrics
[6] University of Novara,Department of Pediatrics
[7] University of Perugia,Department of Pediatrics
[8] Policlinico Universitario di Messina,Dipartimento di Scienze Pediatriche Mediche e Chirurgiche
来源：
Journal of Endocrinological Investigation | 2005年 / 28卷
关键词：
Turner syndrome; liver enzymes; hormonal therapy; autoim-munity; obesity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Elevated liver enzymes can be seen relatively frequently in patients with Turner syndrome (TS), while the pathogenesis of this remains unclear. Our epidemiological and prospective study aimed to investigate: a) the natural 2- yr course of liver disease in a selected cohort of young patients with TS, who had been preliminarily recruited on the basis of persistently elevated liver enzymes; b) the role of prolonged hormonal therapies in the etiology of liver dysfunction. From an overall population of 214 TS patients younger than 20 yr, only 19 (8.9%) were recruited, according to the following inclusion criteria: increased serum concentrations of one or more liver enzymes, exceeding the uppermost limit of the respective normal ranges, and persistence of these liver alterations for 6 months after the preliminary assessment. On the basis of the results of this prospective study, we can conclude that: a) the prevalence of liver abnormalities in girls and adolescents with TS is much lower and more strictly related to hormonal therapies than in TS adults; b) both autoim-munity and obesity are not frequently involved in the etiology of TS liver dysfunction; c) liver damage is either mild or moderate and its severity is not conditioned by karyotype; d) its course may be self-limiting; e) its natural history may be characterized in some cases by a slight deterioration of intrahepatic cholestasis, with no negative repercussions on liver synthetic function.
引用
收藏
页码：720 / 726
页数：6
相关论文
共 99 条
[1]  
Larizza D(2000)Serum liver enzymes in Turner syndrome Eur J Pediatr 159 143-8
[2]  
Locatelli M(1999)Liver abnormalities in Turner syndrome Eur J Pediatr 158 618-23
[3]  
Vitali L(2003)Chronic cholestasis associated with Turner’s syndrome: 12 years of clinical and histopathological follow-up Digestion 67 96-9
[4]  
Salerno M(1999)Biochemical liver abnormalities in Turner’s syndrome Eur J Gastroenterol Hepatol 11 1037-9
[5]  
Di Maio S(2004)Can Turner syndrome teach us about the pathogenesis of chronic cholestasis? Hepatology 40 1226-8
[6]  
Gasprini N(1975)Biliary atresia andthe Dandy-Walker anomaly in a neonate with 45,X Turner’s syndrome J Pathol 115 227-30
[7]  
Rizzo M(1998)Liver abnormalities and portal hypertension in Ullrich-Turner syndrome Am J Med Genet 80 180-2
[8]  
Ferri P(1976)Anomalies hèpatiques avec hypertension portale associèes a un syndrome de Turner Arch Anat Cytol Pathol 24 311-6
[9]  
Vajro P(1990)Development of liver cirrhosis in a female patient with Shereshevskii-Turner syndrome Klin Med (Mosk) 68 95-6
[10]  
Wardi J(1999)Chronic cholestasis associated with Turner’s syndrome Digestion 60 587-9
12345678910